| Added by | mollevi |
|---|---|
| Group name | EquipeCG |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Department of Medical Oncology, Institut Bergonie, 229, Cours de l'Argonne, 33076, Bordeaux, France. g.roubaud@bordeaux.unicancer.fr. Institut Bergonie, Clinical and Epidemiological Research Unit, 33000, Bordeaux, France. v.brouste@bordeaux.unicancer.fr. Department of Medical Oncology, Institut Curie, 25 rue d'Ulm, 75005, Paris, France. philippe.beuzeboc@curie.net. Department of Medical Oncology, Institut Leon Berard, 69000, Lyon, France. aude.flechon@lyon.unicancer.fr. Department of Medical Oncology, Institut Val d'Aurelle, 34000, Montpellier, France. diego.tosi@icm.unicancer.fr. Department of Medical Oncology, CHU Dupuytren, 87000, Limoges, France. sandrine.lavau-denes@chu-limoges.fr. Department of Medical Oncology, Institut Claudius Regaud, 31000, Toulouse, France. chevreau.christine@iuct-oncopole.fr. Centre Hospitalier Universitaire Saint Louis, 75010, Paris, France. stephane.culine@sls.aphp.fr. European Hospital Georges Pompidou, 75015, Paris, France. stephane.oudard@aphp.fr. Department of Medical Oncology, Institut Bergonie, 229, Cours de l'Argonne, 33076, Bordeaux, France. amandine.quivy@chu-bordeaux.fr. Institut de Recherche en Cancerologie de Montpellier & Universite de Montpellier 1, INSERM U896, F-34000, Montpellier, France. philippe.pourquier@inserm.fr. Department of Medical Oncology, Institut Bergonie, 229, Cours de l'Argonne, 33076, Bordeaux, France. nadine.houede@chu-nimes.fr. Department of Medical Oncology, CHU Caremeau, 30029, Nimes, France. nadine.houede@chu-nimes.fr. alt-title: Journal of negative results in biomedicine number: 1 accession-num: 26555878 |
| Tags | _EndnoteXML import |
| Date Added | 2018/07/20 - 10:05:58 |
| Date Modified | 2018/07/20 - 10:05:58 |
| Parent item | Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients |
Institut de Recherche en Cancérologie de
